Kimia Biosciences Limited receives permission to manufacture Bilastine API

Kimia Biosciences Limited has been granted 'permission to manufacture new API for sale or for distribution' namely Bilastine by Central Drugs Standard Conirol Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi -110002 (India) Vide permission No. MF/SND/2I/OOOOTZ in FORM cr-22 under Drugs & cosmetics Acts & Rules thereunder.

Shares of Kimia Biosciences Limited was last trading in BSE at Rs.39.8 as compared to the previous close of Rs. 39.9. The total number of shares traded during the day was 485 in over 14 trades.

The stock hit an intraday high of Rs. 40 and intraday low of 39. The net turnover during the day was Rs. 19129.

Source : Equity Bulls

Keywords